Published on Tuesday November 05, 2024
Smooth Drug Development October 2024 News Release
Monthly News – October 2024
We are pleased to share the latest updates from Smooth Drug Development for October 2024.
New Projects
We continue to expand our portfolio with exciting new opportunities:
Full-Service Clinical Trial:
- Finalizing a comprehensive service agreement for a Phase III trial in gynecology.
Medical Writing Services:
- Signing a contract for a bioequivalence study with Semaglutide.
Clinical and Scientific Departments News:
- Nimesulide Trial: Enrollment successfully completed.
- Bempedoic Acid Trials: Two new trials were initiated.
- Oncology BE Study: Enrollment of 42 subjects achieved.
- Pembrolizumab Trial: Enrollment reached 20 patients.
These achievements demonstrate our commitment to advancing research and providing high-quality clinical trial services.
Business Development News:
This month, our Business Development team actively participated in key industry events and initiatives:
- Attended the BIOPROM Forum in Europe.
- Attended the CPHI in Italy.
- On 11 November 2024, our Business Development Director met with Clinical Research Malaysia (CRM) to explore thriving clinical research initiatives in Malaysia.